Hyperhomocysteinemia has been associated with both vascular structure alter
ations and vascular clinical end points. To assess the relation between pla
sma homocysteine, structure and function of large arteries, and the presenc
e of clinical vascular disease, we investigated a population of 236 hyperte
nsive patients. We estimated arterial stiffness by measuring the carotid-fe
moral pulse wave velocity. Total plasma homocysteine was determined by fluo
rometric high-performance liquid chromatography. The presence of cardiovasc
ular disease was defined on the basis of clinical events, including coronar
y heart disease, cerebrovascular disease, and peripheral vascular disease.
In this population, pulse wave velocity was positively correlated with homo
cysteine, even after adjustments for age, mean blood pressure, extent of at
herosclerosis, and creatinine clearance (P=0.016). Analysis of variance sho
wed statistically significant differences between the mean values of homocy
steine, creatinine clearance, and pulse wave velocity according to the exte
nt of atherosclerosis, with an increase in these 3 parameters concomitant w
ith an increase in the number of vascular sites involved with atheroscleros
is. In conclusion, in hypertensive patients the levels of homocysteine are
strongly and independently correlated to arterial stiffness measured by aor
tic pulse wave velocity. Plasma homocysteine, creatinine clearance, and aor
tic pulse wave velocity are higher in patients presenting with clinical vas
cular disease. These results suggest that the evaluation of aortic distensi
bility and homocysteine levels can help in cardiovascular risk assessment i
n hypertensive populations.